Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Animal models in scleroderma.

Stephen H Clark1

  • 1University of Connecticut Health Center, Farmington, CT 06030, USA. sclark@nso2.uchc.edu

Current Rheumatology Reports
|March 12, 2005
PubMed
Summary
This summary is machine-generated.

Scleroderma, a fibrotic connective tissue disease, impacts skin and organs. Mouse models help researchers understand the cellular and molecular mechanisms driving fibrosis in this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ehrlichiosis and anaplasmosis subcommittee report to the Tick-borne Disease Working Group.

Ticks and tick-borne diseases·2021
Same author

Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.

Arthritis & rheumatology (Hoboken, N.J.)·2016
Same author

Differences between Mice and Humans in Regulation and the Molecular Network of Collagen, Type III, Alpha-1 at the Gene Expression Level: Obstacles that Translational Research Must Overcome.

International journal of molecular sciences·2015
Same author

Parabiosis model does not show presence of circulating osteoprogenitor cells.

Genesis (New York, N.Y. : 2000)·2010
Same author

Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells.

Journal of cellular physiology·2009
Same author

Regulation of collagen gene expression in the Tsk2 mouse.

Journal of cellular physiology·2007
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
Same journal

Management of IgG4-Related Disease.

Current rheumatology reports·2026
See all related articles

Area of Science:

  • Connective tissue diseases
  • Fibrosis research
  • Immunology and pathology

Background:

  • Scleroderma, or systemic sclerosis, is a chronic autoimmune disease characterized by excessive collagen deposition and fibrosis.
  • Fibrosis in scleroderma affects not only the skin but also internal organs, leading to significant morbidity.
  • Currently, no cure exists for scleroderma, highlighting the need for deeper understanding of its pathogenesis.

Purpose of the Study:

  • To review and summarize research utilizing mouse models of scleroderma.
  • To elucidate the cellular and molecular events underlying fibrosis in scleroderma.
  • To provide insights into the onset and maintenance of fibrotic states in experimental paradigms.

Main Methods:

  • Focus on established mouse models that recapitulate key features of human scleroderma.

Related Experiment Videos

  • Analysis of studies investigating cellular mechanisms of fibrosis in these models.
  • Review of research examining molecular pathways involved in collagen synthesis and deposition.

    • Main Results:

    • Mouse models exhibit key scleroderma features, including skin and organ fibrosis.
    • Specific cellular players and molecular signaling pathways driving fibrosis have been identified.
    • These models allow for the study of fibrosis progression and potential therapeutic targets.

    Conclusions:

    • Mouse models are invaluable tools for dissecting scleroderma pathophysiology.
    • Understanding cellular and molecular events is crucial for developing effective treatments.
    • Further research with these models can advance the search for a cure for systemic sclerosis.